Parental multiple endocrine neoplasia type 1 (MEN 1) is associated with increased offspring childhood mortality.
Information regarding the impact of parental multiple endocrine neoplasia type 1 (MEN 1) on neonatal outcomes is limited to case reports. To determine the impact of parental MEN 1 on neonatal outcomes. Retrospective cohort analysis of the Tasman 1 MEN 1 kindred stratified by whether birth occurred before ('historical cohort') or after ('contemporary cohort') prospective screening commenced. The historical cohort included kindred members born between 1825-1984 (n=341 children with a MEN 1 positive (MEN 1+) parent and n=314 children with MEN 1 negative (MEN 1-) parents). The contemporary cohort included neonates (n=52) of MEN 1+ women (n=21) managed at a tertiary referral hospital between 1985-2018. Historical cohort: compared to MEN 1- parents, children of MEN 1+ parents were more likely to die postpartum (HR 4.6, p=0.046 at 6 months of age). Excess mortality at 15 years of age was observed for children of MEN 1+ mothers (HR 8.50, p=0.002) and fathers (HR 3.82, p=0.03).Contemporary cohort: neonates of MEN 1+ mothers were more likely have low birth weight (28.9% vs 6.7%, p=0.01), admitted to a higher care nursery (40.4% vs 17%, p=0.02) and require a longer median postnatal stay (5 vs 4 days, p=0.009) compared to the Australian average. Isolated antenatal hypercalcemia did not significantly alter neonatal outcomes. Children with a MEN 1+ parent are disproportionately vulnerable postpartum. Neonates of MEN 1+ mothers remain vulnerable despite contemporary care. The excess risk was not fully explained by maternal MEN 1 or antenatal hypercalcemia.